Skip to Main Content

Author Details

Eleonora Scarlata
Research Institute of the McGill University Health Center (RI-MUHC)
1999
38
13
PMIDPaper TitleJournal TitlePublished Year
37037938A DNA copy number alteration classifier as a prognostic tool for prostate cancer patients.Br J Cancer2023
37126232Multimodal Biomarkers That Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance.J Urol2023
37073437Cell-by-cell quantification of the androgen receptor in benign and malignant prostate leads to a better understanding of changes linked to cancer initiation and progression.J Pathol Clin Res2023
35204109Peroxiredoxin 6 Peroxidase and Ca<sup>2+</sup>-Independent Phospholipase A<sub>2</sub> Activities Are Essential to Support Male-Mouse Fertility.Antioxidants (Basel)2022
35411033Fatty acid oxidation enzyme ο3, ο2-enoyl-CoA isomerase 1 (ECI1) drives aggressive tumor phenotype and predicts poor clinical outcome in prostate cancer patients.Oncogene2022
37021966OXIDATIVE STRESS AND REPRODUCTIVE FUNCTION: The protection of mammalian spermatozoa against oxidative stress.Reproduction2022
32668798A Novel Combination of γ-Tocopherol-Rich Mixture of Tocopherols and Ascorbic Acid Restores Fertility in Cases of Tyrosine Nitration-Associated Male Infertility in Mice.Antioxidants (Basel)2020
31891662Antioxidant Enzymes and Male Fertility: Lessons from Knockout Models.Antioxid Redox Signal2020
32093059Long-Term Adverse Effects of Oxidative Stress on Rat Epididymis and Spermatozoa.Antioxidants (Basel)2020
32763409Design and Development of a Fully Synthetic Multiplex Ligation-Dependent Probe Amplification-Based Probe Mix for Detection of Copy Number Alterations in Prostate Cancer Formalin-Fixed, Paraffin-Embedded Tissue Samples.J Mol Diagn2020
31633066Snap29 mutant mice recapitulate neurological and ophthalmological abnormalities associated with 22q11 and CEDNIK syndrome.Commun Biol2019
30140035The combination of PTEN deletion and 16p13.3 gain in prostate cancer provides additional prognostic information in patients treated with radical prostatectomy.Mod Pathol2019
30113732Optimization of the 2014 Gleason grade grouping in a Canadian cohort of patients with localized prostate cancer.BJU Int2019
30136199The relationship between body-mass index, physical activity, and pathologic and clinical outcomes after radical prostatectomy for prostate cancer.World J Urol2019
31433512A three-gene DNA methylation biomarker accurately classifies early stage prostate cancer.Prostate2019
31340802Improving ultrasound-based prostate volume estimation.BMC Urol2019
28993510Genomic Gain of 16p13.3 in Prostate Cancer Predicts Poor Clinical Outcome after Surgical Intervention.Mol Cancer Res2018
28724614Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancer.Genes Dev2017
28152543Asporin is a stromally expressed marker associated with prostate cancer progression.Br J Cancer2017
29021631Deficiency of peroxiredoxin 6 or inhibition of its phospholipase A<sub>2</sub> activity impair the in vitro sperm fertilizing competence in mice.Sci Rep2017
25046623A combination of hemostatic agents may safely replace deep medullary suture during laparoscopic partial nephrectomy in a pig model.J Urol2015
26714499The dog prostate cancer (DPC-1) model: a reliable tool for molecular imaging of prostate tumors and metastases.EJNMMI Res2015
25578541Electrochemical red-ox therapy of prostate cancer in nude mice.Bioelectrochemistry2015
24406017The prognostic role of ERG immunopositivity in prostatic acinar adenocarcinoma: a study including 454 cases and review of the literature.Hum Pathol2014
25152453Biopsy characteristics in men with a preoperative diagnosis of prostatic adenocarcinoma with high Gleason score (8-10) predict pathologic outcome in radical prostatectomy.Hum Pathol2014
23680311Endoscopic vascular targeted photodynamic therapy with the photosensitizer WST11 for benign prostatic hyperplasia in the preclinical dog model.J Urol2013
24194978Strategies for biochemical and pathologic quality assurance in a large multi-institutional biorepository; The experience of the PROCURE Quebec Prostate Cancer Biobank.Biopreserv Biobank2013
23906537The Fer tyrosine kinase acts as a downstream interleukin-6 effector of androgen receptor activation in prostate cancer.Mol Cell Endocrinol2013
21882212Refining the orthotopic dog prostate cancer (DPC)-1 model to better bridge the gap between rodents and men.Prostate2012
23401739The 16p13.3 (PDPK1) Genomic Gain in Prostate Cancer: A Potential Role in Disease Progression.Transl Oncol2012
22200970Banking of fresh-frozen prostate tissue using the alternate mirror image protocol: methods, validation, and impact on the pathological prognostic parameters in radical prostatectomy.Cell Tissue Bank2012
21600602Preclinical study of the novel vascular occluding agent, WST11, for photodynamic therapy of the canine prostate.J Urol2011
19147545The Fer tyrosine kinase cooperates with interleukin-6 to activate signal transducer and activator of transcription 3 and promote human prostate cancer cell growth.Mol Cancer Res2009
20061787Inhibition of mammalian target of rapamycin as a therapeutic strategy in the management of bladder cancer.Cancer Biol Ther2009
19399787Botulinum toxin type A inhibits the growth of LNCaP human prostate cancer cells in vitro and in vivo.Prostate2009
16857789Isolation of human prostatic epithelial plasma membranes for proteomics using mirror image tissue banking of radical prostatectomy specimens.Clin Cancer Res2006
10481620Filamentous intranuclear inclusion bodies in psittacine birds. A structural and ultrastructural study.Zentralbl Veterinarmed B1999
10204226Rupture of the gracilis muscle in Iberian pigs at slaughter.Vet Rec1999
  • 1 - 38 of 38

Recommended Authors

Cumming School of Medicine, University of Calgary
Career Start Year 2016
Number of shared co-authors 1
College of Medicine and Health Sciences, United Arab Emirates University
Career Start Year 2010
Number of shared co-authors 1
Baylor College of Medicine
Career Start Year 2009
Number of shared co-authors 1
University of British Columbia
Career Start Year 2008
Number of shared co-authors 4
Sandra and Edward Meyer Cancer Center
Career Start Year 2008
Number of shared co-authors 5
Center for Comparative Medicine, Baylor College of Medicine
Career Start Year 2008
Number of shared co-authors 1
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Career Start Year 2005
Number of shared co-authors 8
University of California San Diego
Career Start Year 2005
Number of shared co-authors 1
Charite - University Hospital Berlin
Career Start Year 2004
Number of shared co-authors 2
Korea National College of Agriculture and Fisheries, Sangji University
Career Start Year 2004
Number of shared co-authors 0
University of British Columbia
Career Start Year 2004
Number of shared co-authors 4
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 6
Foundation for the Finnish Cancer Institute
Career Start Year 1999
Number of shared co-authors 0
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Career Start Year 1999
Number of shared co-authors 12
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 5
Career Start Year 1995
Number of shared co-authors 2
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 4
University of Colorado School of Medicine
Career Start Year 1991
Number of shared co-authors 3
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 4
University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
Career Start Year 1989
Number of shared co-authors 0
University of Colorado Anschutz Medical Campus
Career Start Year 1988
Number of shared co-authors 0
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 1988
Number of shared co-authors 4
Skane University Hospital, Lund University
Career Start Year 1987
Number of shared co-authors 6
University of Oxford
Career Start Year 1987
Number of shared co-authors 5
Eastern Virginia Medical School
Career Start Year 1985
Number of shared co-authors 9
University of Washington School of Medicine
Career Start Year 1980
Number of shared co-authors 11
The Brady Urological Institute, The Johns Hopkins School of Medicine
Career Start Year 1979
Number of shared co-authors 6
Barts Cancer Institute, Queen Mary University of London
Career Start Year 1975
Number of shared co-authors 4
University Health Network, University of Toronto
Career Start Year 1974
Number of shared co-authors 20
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 0

Collaborators

McGill University Health Centre, McGill University
Co-authored papers 26
McGill University Health Centre, McGill University
Co-authored papers 21
McGill University Health Centre, McGill University
Co-authored papers 19
McGill University and the Research Institute of the McGill University Health Centre
Co-authored papers 8
University of Montreal Health Center
Co-authored papers 5
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers 4
Queen's University
Co-authored papers 4
CHU de Quebec-Universite Laval
Co-authored papers 4
Queen's University
Co-authored papers 4
University of Edinburgh
Co-authored papers 4
Current affiliation: IMV Inc.
Co-authored papers 3
Centre Hospitalier de l'Universite de Montreal
Co-authored papers 3
Queen's University
Co-authored papers 3
Schulich School of Medicine and Dentistry, University of Western Ontario
Co-authored papers 2
Queen's University Cancer Research Institute
Co-authored papers 2
University of California los angeles
Co-authored papers 2
University of Western Ontario
Co-authored papers 2
University of British Columbia
Co-authored papers 2
Research Institute of the McGill University Health Centre
Co-authored papers 2
Ontario Institute for Cancer Research
Co-authored papers 2
Western University and London Regional Cancer Program
Co-authored papers 2
Ontario Institute for Cancer Research (OICR)
Co-authored papers 1
University of Oxford, John Radcliffe Hospital
Co-authored papers 1
McGill University and the Research Institute of the McGill University Health Centre
Co-authored papers 1
Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University
Co-authored papers 1
University
Co-authored papers 1
Co-authored papers 1
Queen's University
Co-authored papers 1
University of Sao Paulo
Co-authored papers 1
University of British Columbia
Co-authored papers 1